跳至主要内容
临床试验/NCT02168426
NCT02168426已完成3 期

Randomized Control Trial on Seprafilm and Guardix in Preventing Ileus

Gachon University Gil Medical Center1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2013年8月最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
200
试验地点
1
主要终点
ileus rate

研究概览

简要总结

The purpose of the study is to evaluate the efficacy of Seprafilm and guardix in reducing the incidence of bowel obstruction and to evaluate the incidence of all serious adverse events (SAEs) associated with the use of Seprafilm and guardix occurring within 30 days postoperatively.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
25 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of GI cancer

排除标准

  • Withdrew consent
  • Distant metastasis
  • Liver dysfunction (serum total bilirubin >2.0 mg/dL)
  • Renal failure (serum creatinine >1.5 mg/dL)
  • A past history of small bowel obstruction.

结局指标

主要结局

ileus rate

时间窗: within 60 days

Reducing the incidence of bowel obstruction following intestinal resection, and subsequently, reducing the number of re-operations

次要结局

  • adverse effect rate(within 60 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Won-Suk Lee

Won-Suk Lee

Gachon University Gil Medical Center

研究点 (1)

Loading locations...

相似试验